Susana Remesar , David Cano-Terriza , Patrocinio Morrondo , Álvaro Oleaga , Barbara Moroni , Nuno Santos , Riccardo Orusa , Lisa Guardone , Pablo Díaz , David García-Dios , Saúl Jiménez-Ruiz , Joana Ferreira- e-Silva , Moisés Gonzálvez , Serena Robetto , Ignacio García-Bocanegra
{"title":"Prevalence of tick-borne pathogens in grey wolves (Canis lupus) in southwestern Europe","authors":"Susana Remesar , David Cano-Terriza , Patrocinio Morrondo , Álvaro Oleaga , Barbara Moroni , Nuno Santos , Riccardo Orusa , Lisa Guardone , Pablo Díaz , David García-Dios , Saúl Jiménez-Ruiz , Joana Ferreira- e-Silva , Moisés Gonzálvez , Serena Robetto , Ignacio García-Bocanegra","doi":"10.1016/j.vetmic.2025.110579","DOIUrl":null,"url":null,"abstract":"<div><div>In Europe, studies on tick-borne pathogens (TBPs) in wolves are limited, primarily focusing on one population. This study aimed to assess the prevalence of TBPs in grey wolves (<em>Canis lupus</em>) from Spain (n = 129), Italy (n = 113), and Portugal (n = 43) between 2001 and 2023. The presence of <em>Anaplasma</em> spp., <em>Ehrlichia</em> spp., <em>Hepatozoon</em> spp. and piroplasm DNA was analyzed in spleen samples, and risk factors for <em>Hepatozoon canis</em> prevalence were evaluated using a generalized linear model<em>.</em> Overall, 93.3 % (266/285) wolves tested positive to at least one TBP, being <em>H. canis</em> the most prevalent (91.6 %). <em>Babesia canis</em> (1.8 %), <em>Anaplasma phagocytophilum</em> (1.4 %), and <em>Babesia capreoli</em> (0.7 %) were detected in small percentages and <em>Ehrlichia</em> spp. and <em>Theileria</em> spp. were not found. Coinfections involving <em>H. canis</em> + <em>B. canis</em> (1.8 %) as well as <em>A. phagocytophilum</em> + <em>B. capreoli</em> (0.4 %) were detected. <em>Hepatozoon canis</em> prevalence was significantly higher in Spain than in Portugal and it was higher in young compared to subadult individuals. The phylogenetic analysis showed the existence of well-defined clades of <em>H. canis</em>. The high prevalence of <em>H. canis</em> indicates that this pathogen is endemic in wolves from these three countries, whereas the importance of <em>Anaplasma</em>, <em>Ehrlichia</em> and piroplasm species seems to be negligible. Our results show a high nucleotide diversity among the <em>H. canis</em> sequences. In addition, our data reveals that wolves from the study countries are infected with TBPs, which could be of health concern. These findings highlight the importance of performing epidemiological studies in wildlife.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"307 ","pages":"Article 110579"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113525002147","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
In Europe, studies on tick-borne pathogens (TBPs) in wolves are limited, primarily focusing on one population. This study aimed to assess the prevalence of TBPs in grey wolves (Canis lupus) from Spain (n = 129), Italy (n = 113), and Portugal (n = 43) between 2001 and 2023. The presence of Anaplasma spp., Ehrlichia spp., Hepatozoon spp. and piroplasm DNA was analyzed in spleen samples, and risk factors for Hepatozoon canis prevalence were evaluated using a generalized linear model. Overall, 93.3 % (266/285) wolves tested positive to at least one TBP, being H. canis the most prevalent (91.6 %). Babesia canis (1.8 %), Anaplasma phagocytophilum (1.4 %), and Babesia capreoli (0.7 %) were detected in small percentages and Ehrlichia spp. and Theileria spp. were not found. Coinfections involving H. canis + B. canis (1.8 %) as well as A. phagocytophilum + B. capreoli (0.4 %) were detected. Hepatozoon canis prevalence was significantly higher in Spain than in Portugal and it was higher in young compared to subadult individuals. The phylogenetic analysis showed the existence of well-defined clades of H. canis. The high prevalence of H. canis indicates that this pathogen is endemic in wolves from these three countries, whereas the importance of Anaplasma, Ehrlichia and piroplasm species seems to be negligible. Our results show a high nucleotide diversity among the H. canis sequences. In addition, our data reveals that wolves from the study countries are infected with TBPs, which could be of health concern. These findings highlight the importance of performing epidemiological studies in wildlife.
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.